Systemic antibody responses to gut microbes in health and disease

Gut Microbes

Volumn 3, Issue 1, 2012, Pages

  Zimmermann, Kathrin ^a   Haas, Anna ^a   Oxenius, Annette ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Enteropathy; Microbiota; Systemic antibody responses

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN G; RIBOSOME PROTEIN;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSLOCATION; CANDIDA ALBICANS; CROHN DISEASE; CROSS REACTION; CYTOKINE RESPONSE; ENTERITIS; ENTEROPATHY; ESCHERICHIA COLI; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE SYSTEM; IMMUNOREGULATION; INTESTINE; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; LYMPHOCYTE ACTIVATION; MESENTERY LYMPH NODE; MICROBIAL IDENTIFICATION; MUCOSAL IMMUNITY; NEISSERIA GONORRHOEAE; NONHUMAN; PERMEABILITY BARRIER; ULCERATIVE COLITIS;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 84858607062     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.19344     Document Type: Article

References (67)

1. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34:637-50; PMID: 21616434; http://dx.doi.org/10.1016/j.immuni.2011.05.006
2. Beutler B. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 2009; 227:248-63; PMID:19120489; http://dx.doi.org/10.1111/j.1600-065X.2008.00733.x
3. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-8; PMID:15831718; http://dx.doi.org/10.1126/science.1110591
4. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al & MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID: 20203603; http://dx.doi.org/10.1038/nature08821
5. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10:159-69; PMID: 20182457; http://dx.doi.org/10.1038/nri2710
6. Mueller C, Macpherson AJ. Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 2006; 55:276-84; PMID:16407387; http://dx.doi.org/10.1136/gut.2004.054098
7. Feng T, Elson CO. Adaptive immunity in the hostmicrobiota dialog. Mucosal Immunol 2011; 4:15-21; PMID:20944557; http://dx.doi.org/10.1038/mi.2010.60
8. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 2008; 105:15064-9; PMID:18806221; http://dx.doi.org/10.1073/pnas.0803124105
9. Mukherjee S, Vaishnava S, Hooper LV. Multi-layered regulation of intestinal antimicrobial defense. Cell Mol Life Sci 2008; 65:3019-27; PMID:18560756; http://dx.doi.org/10.1007/s00018-008-8182-3
10. Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 2008; 1:11-22; PMID: 19079156; http://dx.doi.org/10.1038/mi.2007.6
11. Sansonetti PJ. To be or not to be a pathogen: that is the mucosally relevant question. Mucosal Immunol 2011; 4:8-14; PMID:21150896; http://dx.doi.org/10.1038/mi.2010.77
12. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005; 307:254-8; PMID: 15653504; http://dx.doi.org/10.1126/science.1102901
13. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303:1662-5; PMID:15016999; http://dx.doi.org/10.1126/science.1091334
14. Konrad A, Cong Y, Duck W, Borlaza R, Elson CO. Tight mucosal compartmentation of the murine immune response to antigens of the enteric micro-biota. Gastroenterology 2006; 130:2050-9; PMID: 16762628; http://dx.doi.org/10.1053/j.gastro.2006.02.055
15. Haas A, Zimmermann K, Graw F, Slack E, Rusert P, Ledergerber B, et al & Swiss HIV Cohort Study. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut 2011; 60:1506-19; PMID:21515549; http://dx.doi.org/10.1136/gut.2010.224774
16. Allan E, Poxton IR, Barclay GR. Anti-bacteroides lipopolysaccharide IgG levels in healthy adults and sepsis patients. FEMS Immunol Med Microbiol 1995; 11:5-12; PMID:7599603; http://dx.doi.org/10.1111/j.1574-695X.1995.tb00072.x
17. Cohen IR, Norins LC. Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M. Science 1966; 152:1257-9; PMID:5327885; http://dx.doi.org/10.1126/science.152.3726.1257
18. Scott H, Rognum TO, Midtvedt T, Brandtzaeg P. Agerelated changes of human serum antibodies to dietary and colonic bacterial antigens measured by an enzymelinked immunosorbent assay. Acta Pathol Microbiol Immunol Scand C 1985; 93:65-70; PMID:4013749
19. Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995; 36:897-901; PMID:7615280; http://dx.doi.org/10.1136/gut.36.6.897
20. Adams RJ, Heazlewood SP, Gilshenan KS, O'Brien M, McGuckin MA, Florin TH. IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin. Am J Gastroenterol 2008; 103:386-96; PMID:17924999; http://dx.doi.org/10.1111/j.1572-0241.2007.01577.x
21. Devlin SM, Yang H, Ippoliti A, Taylor KD, Landers CJ, Su X, et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology 2007; 132:576-86; PMID:17258734; http://dx.doi.org/10.1053/j.gastro.2006.11.013
22. Joossens S, Colombel JF, Landers C, Poulain D, Geboes K, Bossuyt X, et al. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis. Gut 2006; 55:1667-9; PMID:16687433; http://dx.doi.org/10.1136/gut.2005.089623
23. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006; 131:366-78;PMID: 16890590; http://dx.doi.org/10.1053/j.gastro.2006.04.030
24. Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007; 56:1394-403; PMID:17456509; http://dx.doi.org/10.1136/gut.2006.108043
25. Lindberg E, Magnusson KE, Tysk C, Järnerot G. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut 1992; 33:909-13; PMID:1644330; http://dx.doi.org/10.1136/gut.33.7.909
26. Furrie E, Macfarlane S, Cummings JH, Macfarlane GT. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut 2004; 53: 91-8;PMID:14684582; http://dx.doi.org/10.1136/gut.53.1.91
27. O'Mahony S, Anderson N, Nuki G, Ferguson A. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease. Ann Rheum Dis 1992; 51:1296-300; PMID: 1485810; http://dx.doi.org/10.1136/ard.51.12.1296
28. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004; 113:1296-306; PMID:15124021
29. Dotan I. New serologic markers for inflammatory bowel disease diagnosis. Dig Dis 2010; 28:418-23; PMID:20926866; http://dx.doi.org/10.1159/000320396
30. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cellindependent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000; 288:2222-6; PMID:10864873; http://dx.doi.org/10.1126/science.288.5474.2222.
31. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9:799-809; PMID:19855405; http://dx.doi.org/10.1038/nri2653
32. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003; 18:479-97; PMID: 12702039; http://dx.doi.org/10.1046/j.1440-1746.2003.03032.x
33. Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 1999; 473:11-30; PMID:10659341; http://dx.doi.org/10.1007/978-1-4615-4143-1_2
34. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001; 14:617-29; PMID:11371363; http://dx.doi.org/10.1016/S1074-7613(01)00129-7
35. Macpherson AJ, Slack E. The functional interactions of commensal bacteria with intestinal secretory IgA. Curr Opin Gastroenterol 2007; 23:673-8; PMID:17906446; http://dx.doi.org/10.1097/MOG.0b013e3282f0d012
36. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009; 15:100-13; PMID:18623167; http://dx.doi.org/10.1002/ibd.20539
37. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 2011; 140:1704-12; PMID:21530736; http://dx.doi.org/10.1053/j.gastro.2011.02.046
38. Scharl M, Rogler G. Microbial sensing by the intestinal epithelium in the pathogenesis of inflammatory bowel disease. Int J Inflam 2010; 2010:671258; PMID: 21188218; http://dx.doi.org/10.4061/2010/671258
39. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004; 3:394-400; PMID:15288007; http://dx.doi.org/10.1016/j.autrev.2004.03.002
40. Teahon K, Smethurst P, Levi AJ, Menzies IS, Bjarnason I. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992; 33:320-3; PMID:1568650; http://dx.doi.org/10.1136/gut.33.3.320
41. Peeters M, Geypens B, Claus D, Nevens H, Ghoos Y, Verbeke G, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997; 113:802-7; PMID:9287971; http://dx.doi.org/10.1016/S0016-5085(97)70174-4
42. Schultsz C, Van Den Berg FM, Ten Kate FW, Tytgat GN, Dankert J. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 1999; 117:1089-97; PMID:10535871; http://dx.doi.org/10.1016/S0016-5085(99)70393-8
43. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Büschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102:448-55; PMID:8536356; http://dx.doi.org/10.1111/j.1365-2249.1995.tb03836.x
44. Stecher B, Hardt WD. Mechanisms controlling pathogen colonization of the gut. Curr Opin Microbiol 2011; 14:82-91; PMID:21036098; http://dx.doi.org/10.1016/j.mib.2010.10.003
45. Viswanathan VK, Hodges K, Hecht G. Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat Rev Microbiol 2009; 7:110-9; PMID:19116615
46. Friis LM, Keelan M, Taylor DE. Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2. Infect Immun 2009; 77:1553-60; PMID:19139198; http://dx.doi.org/10.1128/IAI.00707-08
47. Gerlach RG, Cláudio N, Rohde M, Jäckel D, Wagner C, Hensel M. Cooperation of Salmonella pathogenicity islands 1 and 4 is required to breach epithelial barriers. Cell Microbiol 2008; 10:2364-76; PMID:18671822; http://dx.doi.org/10.1111/j.14625822.2008.01218.x
48. Gill N, Wlodaska M, Finlay BB. Roadblocks in the gut: barriers to enteric infection. Cell Microbiol 2011; 13:660-9; PMID:21392202; http://dx.doi.org/10.1111/j.1462-5822.2011.01578.x
49. Currie CG, McCallum K, Poxton IR. Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease. J Med Microbiol 2001; 50:345-54; PMID:11289520
50. Sánchez-Hurtado K, Corretge M, Mutlu E, McIlhagger R, Starr JM, Poxton IR. Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controls. J Med Microbiol 2008; 57:717-24; PMID:18480328; http://dx.doi.org/10.1099/jmm.0.47713-0
51. Rokosz N, Rastawicki W, Jagielski M. [Evaluation of usefulness of commercial recomwell Campylobacter enzyme-linked immunosorbent assays for routine serodiagnosis of Campylobacter jejuni and Campylobacter coli infections]. Med Dosw Mikrobiol 2008; 60:289-95; PMID:19382600
52. Robin G, Cohen D, Orr N, Markus I, Slepon R, Ashkenazi S, et al. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection. J Infect Dis 1997; 175:1128-33; PMID:9129076; http://dx.doi.org/10.1086/516452
53. Fadeel MA, House BL, Wasfy MM, Klena JD, Habashy EE, Said MM, et al. Evaluation of a newly developed ELISA against Widal, TUBEX-TF and Typhidot for typhoid fever surveillance. J Infect Dev Ctries 2011; 5:169-75; PMID:21444985; http://dx.doi.org/10.3855/jidc.1339
54. Jayasekera CR, Harris JB, Bhuiyan S, Chowdhury F, Khan AI, Faruque AS, et al. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J Infect Dis 2008; 198:1055-61; PMID:18729782; http://dx.doi.org/10.1086/591500
55. Sharpstone DR, Duggal A, Gazzard BG. Inflammatory bowel disease in individuals seropositive for the human immunodeficiency virus. Eur J Gastroenterol Hepatol 1996; 8:575-8; PMID:8823573; http://dx.doi.org/10.1097/00042737-199606000-00015
56. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008; 1:23-30; PMID:19079157; http://dx.doi.org/10.1038/mi.2007.1
57. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59; PMID:15365096; http://dx.doi.org/10.1084/jem.20040874
58. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77:11708-17; PMID:14557656; http://dx.doi.org/10.1128/JVI.77.21.11708-11717.2003
59. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71; PMID: 17115046; http://dx.doi.org/10.1038/nm1511
60. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010; 6:e1000852; PMID:20386714; http://dx.doi.org/10.1371/journal.ppat.1000852
61. Castro G, Martinez R. Relationship between serum and saliva antibodies to Candida and isolation of Candida species from the mucosa of HIV-infected individuals. Mycoses 2009; 52:246-50; PMID:18643885; http://dx.doi.org/10.1111/j.1439-0507.2008.01594.x
62. Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Long R, et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 2008; 135:226-33; PMID:18457674; http://dx.doi.org/10.1053/j.gastro.2008.03.022
63. Haas A, Rehr M, Graw F, Rusert P, Bossart W, Kuster H, et al. HIV-1 replication activates CD4+ T cells with specificities for persistent herpes viruses. EMBO Mol Med 2010; 2:231-44; PMID:20533427
64. Redd AD, Dabitao D, Bream JH, Charvat B, Laeyendecker O, Kiwanuka N, et al. Microbial trans-location, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci U S A 2009; 106:6718-23; PMID:19357303; http://dx.doi.org/10.1073/pnas.0901983106
65. Lien E, Aukrust P, Sundan A, Müller F, Frøland SS, Espevik T. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 1998; 92:2084-92; PMID:9731066
66. Kamat A, Ancuta P, Blumberg RS, Gabuzda D. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS One 2010; 5:e15533; PMID:21125014; http://dx.doi.org/10.1371/journal.pone.0015533
67. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9:235-45; PMID:19319142; http://dx.doi.org/10.1038/nri2524